Deenstra Duco D, Nijziel Marten R, Aldenkamp Arnoud F, van Balkom Roland H H, Smeenk Frank W J M
Catharina Ziekenhuis, afd. Longgeneeskunde, Eindhoven.
Catharina Ziekenhuis, afd. Hematologie, Eindhoven.
Ned Tijdschr Geneeskd. 2020 Jul 2;164:D5116.
Venous thromboembolism (VTE) seems to be an underdiagnosed complication in COVID-19 patients. We present three male patients, aged 67, 29 and 71 years, who were admitted to the hospital with COVID-19. They all showed deterioration in the course of their disease caused by VTE. In our hospital, VTE was diagnosed in 10% of COVID-19 patients admitted to the general ward (non-ICU patients) despite regular thromboprophylaxis. Deterioration in the course of COVID-19 has differential diagnoses such as progression of the infection itself, secondary bacterial pneumonia, left heart failure and in our experience not infrequently VTE. We therefore recommend to consider VTE in COVID-19 patients with a sudden clinical deterioration such as hypotension, tachycardia, unexplained hypoxaemia or insufficient clinical improvement and to perform CT-angiography if indicated. A high dose of thromboprophylaxis in COVID-19 patients may be considered because of increased coagulation activation.
静脉血栓栓塞症(VTE)似乎是新冠肺炎患者中一种未被充分诊断的并发症。我们介绍三名男性患者,年龄分别为67岁、29岁和71岁,他们因新冠肺炎入院。他们在疾病过程中均因VTE而病情恶化。在我们医院,尽管进行了常规的血栓预防,但在普通病房(非重症监护病房患者)收治的新冠肺炎患者中,有10%被诊断出患有VTE。新冠肺炎病程中的病情恶化有多种鉴别诊断,如感染本身的进展、继发性细菌性肺炎、左心衰竭,而根据我们的经验,VTE也并不少见。因此,我们建议对于出现突然临床恶化(如低血压、心动过速、不明原因的低氧血症或临床改善不足)的新冠肺炎患者考虑VTE,并在有指征时进行CT血管造影。由于凝血激活增加,可考虑对新冠肺炎患者进行高剂量的血栓预防。